A multi-center, randomized, open-label, parallel group study of a natural micronized progesterone vaginal tablet as a luteal support agent in Japanese women undergoing assisted reproductive technology
Conclusions
FE 999913 was useful in this trial from the aspects of sufficient supplementation of progesterone, comparable pregnancy rate with that in clinical practice in Japan, and safety.
Clinical trial registration
ClinicalTrials.gov identifier: NCT01710514.
Source: Reproductive Medicine and Biology - Category: OBGYN Source Type: research
More News: Biology | Clinical Trials | ICSI (Intracytoplasmic Sperm Injection) | OBGYN | Pregnancy | Study | Women